Monitor
Flag residents needing review based on medication changes or documentation gaps.
Monitor is the medication-side watchtower: who is on which psychotropic class, whose metabolic labs are due, and which medication-driven monitoring tasks are open — continuously, not on a monthly cycle.
What's in the module
Psychotropic class taxonomy
Medications classify against the platform's psychotropic vocabulary — antipsychotics, sedative-hypnotics, CNS depressants, anticholinergics — with KPI cards counting the residents in each bucket and listing the medications that put them there.
Metabolic monitoring
Every resident on an antipsychotic should have metabolic labs within 90 days. The panel tracks the most recent qualifying lab per resident — current, due soon, or overdue — and opens a task naming the labs needed.
Five monitoring rules
Metabolic labs due, a post-fall safety review while a sedating medication is active, treatment-impact review, refusal trends, and polypharmacy risk (two or more active CNS depressants) — each opening a prioritized monitoring task.
An events log
PRN administrations, adverse effects, and refusals in one trail — so the medication picture and the event record sit on one page.
Regulatory context
Antipsychotics and sedative-hypnotics are the chemical-restraint-relevant classes — the ones surveyors scrutinize under F605 when use lacks a documented clinical indication.